ARTICLES ON HEART FAILURE AND CIRCULATORY DEVICES
Pediatric Ventricular Assist Devices in Europe: 4th Paedi-EUROMACS Registry
The fourth report of the European registry of long-term ventricular assist devices (VADs) in pediatric patients covers the period 2001–2022, analyzing observed data and trends over time.
Transplantation in Fontan: an expert’s perspective
A review commentary on the complex topic of heart transplantation in patients with Fontan circulation physiology, authored by expert Dr. Juan-Miguel Gil-Jaurena.
HeartMate 3 in Patients with Extracorporeal Life Support: Improved Outcomes over Previous Devices and Comparable to Transplantation?
Three-Year Results of the ECSL Registry in Extracorporeal Life Support Patients Receiving HM3 Implants from January 2016 to April 2022 Across 14 Centers, Compared to Other Long-Term Devices.
More challenging yet: outcomes of heart transplantation in children with heterotaxy syndrome
This retrospective study utilized data from the United Network for Organ Sharing (UNOS) and the Pediatric Health Information System (PHIS) to evaluate the outcomes of heart transplantation in children with heterotaxy syndrome. These were compared with outcomes in patients with other congenital heart diseases (CHD) and cardiomyopathies, focusing on survival, rejection, and additional complications.
Heart Transplantation from Pig Xenografts to Humans: Chimera, Science, and Hope
Update on research, experiences, and future perspectives of porcine-to-human cardiac xenotransplantation.
Intraoperative Extracorporeal Support in Lung Transplantation: Where Are We Heading?
A review of the Journal of Clinical Medicine on intraoperative support during lung transplantation compares the use of ECMO with cardiopulmonary bypass.
Controlled Circulatory Death Cardiac Donation: Turning Necessity into Virtue
A retrospective analysis of the United Network for Organ Sharing (UNOS) database on heart transplants from controlled circulatory death (DCD) donations performed in the U.S. from October 2018 to December 2022.
Impella CP® in Myocardial Infarction with Cardiogenic Shock: First Evidence in Over 20 Years
This international, multicenter clinical trial (DanGer study) evaluates the effects of routine implantation of the microaxial flow pump (Impella CP®) compared to conventional treatment in patients with acute myocardial infarction complicated by cardiogenic shock.
Advanced therapies for heart failure: heart transplantation vs. LVAD. How to choose? Expert opinion
An expert commentary by Dra. Sonia Mirabet about choices for advanced heart failure therapies.
Berlin Heart® as a bridge to recovery
A systematic review analyzing nearly 1000 pediatric Berlin Heart® implants to describe the characteristics of patients who achieved successful explantation.